Prognostic Factors for Mortality among Day 100 Survivors after Allogeneic Hematopoietic Cell Transplantation.

about

Prognostic Factors for Mortality among Day 100 Survivors after Allogeneic Hematopoietic Cell Transplantation.

Item

http://www.wikidata.org/entity/Q49709281

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Prognostic Factors for Mortali ...... opoietic Cell Transplantation.

@en

Prognostic Factors for Mortali ...... opoietic Cell Transplantation.

@nl

type

Item

label

Prognostic Factors for Mortali ...... opoietic Cell Transplantation.

@en

Prognostic Factors for Mortali ...... opoietic Cell Transplantation.

@nl

prefLabel

Prognostic Factors for Mortali ...... opoietic Cell Transplantation.

@en

Prognostic Factors for Mortali ...... opoietic Cell Transplantation.

@nl

P1476

Prognostic Factors for Mortali ...... opoietic Cell Transplantation.

@en

P2093

Aaron T Gerds

http://www.w3.org/2001/XMLSchema#string

Betty K Hamilton

http://www.w3.org/2001/XMLSchema#string

Brad Pohlman

http://www.w3.org/2001/XMLSchema#string

Brian Bolwell

http://www.w3.org/2001/XMLSchema#string

Brian Hill

http://www.w3.org/2001/XMLSchema#string

Deepa Jagadeesh

http://www.w3.org/2001/XMLSchema#string

Donna Corrigan

http://www.w3.org/2001/XMLSchema#string

Hien Liu

http://www.w3.org/2001/XMLSchema#string

Lisa A Rybicki

http://www.w3.org/2001/XMLSchema#string

Matt Kalaycio

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study.

Outcomes of hematologic malignancies after unrelated donor hematopoietic cell transplantation according to place of residence

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients.

Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors.

P304

1029-1034

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2018.01.016

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sagar Patel

P577

2018-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29369800

http://www.w3.org/2001/XMLSchema#string

P932

5953837

http://www.w3.org/2001/XMLSchema#string